EDGAR Filing Documents for 0001225208-13-013878

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001225208-13-013878

Filing Date

2013-06-04

Accepted

2013-06-04 17:28:46

Documents

Period of Report

2013-05-31

Document Format Files

Seq	Description	Document	Type	Size
1		doc4.html	4
1		doc4.xml	4	6666
	Complete submission text file	0001225208-13-013878.txt		8180

Mailing Address 755 PAGE MILL RD SUITE A200 PALO ALTO CA 94304

Business Address 755 PAGE MILL RD SUITE A200 PALO ALTO CA 94304 4154935600

Type: 4 | Act: 34 | File No.: 001-32979 | Film No.: 13892373

Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080

Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200

THRESHOLD PHARMACEUTICALS INC (Issuer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations